CLINICAL outcomes and loss to follow-up among people living with HIV participating in the NAMWEZA intervention in Dar es Salaam, Tanzania: A prospective cohort study

AIDS Research and Therapy

Volumn 14, Issue 1, 2017, Pages

  Siril, Hellen N ^a,b   Kaaya, Sylvia F ^a   Smith Fawzi, Mary Kay ^c   Mtisi, Expeditho ^d   Somba, Magreat ^d   Kilewo, Japheth ^a   Mugusi, Ferdinand ^a   Minja, Anna ^d   Kaale, Anna ^d   Todd, Jim ^e,f,g  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b MANAGEMENT AND DEVELOPMENT FOR HEALTH   (Tanzania)

^c HARVARD MEDICAL SCHOOL   (United States)

^d African Academy for Public Health   (Tanzania)

^e NATIONAL INSTITUTE OF MEDICAL RESEARCH   (Tanzania)

^f KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

ART; Dar es Salaam; HIV AIDS; LTFU; NAMWEZA; PLH; Psychosocial; Tanzania

Indexed keywords

ANTIRETROVIRUS AGENT; HEMOGLOBIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE; ANTIRETROVIRAL THERAPY; ARTICLE; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTECTION; PSYCHOSOCIAL CARE; TANZANIA; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT GAIN; ATTITUDE TO HEALTH; BLOOD; HIV INFECTIONS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PSYCHOLOGY; RISK FACTOR;

ADULT; ANTI-HIV AGENTS; ATTITUDE TO HEALTH; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HEMOGLOBINS; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TANZANIA; TREATMENT OUTCOME;

EID: 85016390582     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/s12981-017-0145-z     Document Type: Article

References (40)

1. Miller CM, Ketlhapile M, Rybasack-Smith H, Rosen S. Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int health. 2010;15(Suppl 1):48-54.
2. Dalal RP, Macphail C, Mqhayi M, Wing J, Feldman C, Chersich MF, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008;47(1):101-7.
3. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298.
4. Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L, et al. Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care. 2008;20(3):311-7.
5. Bekolo CE, Webster J, Batenganya M, Sume GE, Kollo B. Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon. BMC Res Notes. 2013;6:512.
6. Sibanda EL, Weller IV, Hakim JG, Cowan FM. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. Aids. 2013;27(17):2787-97.
7. Apisarnthanarak A, Mundy LM. Long-term outcomes of HIV-infected patients with <95% rates of adherence to nonnucleoside reverse-transcriptase inhibitors. Clin Infect Dis. 2010;51(1):115-7.
8. Makunde WH, Francis F, Mmbando BP, Kamugisha ML, Rutta AM, Mandara CI, et al. Lost to follow up and clinical outcomes of HIV adult patients on antiretroviral therapy in care and treatment centres in Tanga City, north-eastern Tanzania. Tanzan Health Res. 2012;14(4):250-6.
9. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PloS ONE. 2009;4(6):e5790.
10. Linthicum KJ, Anyamba A, Britch SC, Chretien JP, Erickson RL, Small J, et al. A Rift Valley fever risk surveillance system for Africa using remotely sensed data: potential for use on other continents. Vet Ital. 2007;43(3):663-74.
11. Ceccarelli L, Salpini R, Moudourou S, Cento V, Santoro MM, Fokam J, et al. Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon. J Med Virol. 2012;84(5):721-7.
12. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to 3 years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Medicine Int Health. 2010;15(Suppl 1):1-15.
13. PROGRAM T. Community care for people living with HIV/AIDS and orphans/vulnerable children report. 2011.
14. Somi G, Keogh SC, Todd J, Kilama B, Wringe A, van den Hombergh J, et al. Low mortality risk but high loss to follow-up among patients in the Tanzanian national HIV care and treatment programme. Trop Med Int Health. 2012;17(4):497-506.
15. Leroy V, Malateste K, Rabie H, Lumbiganon P, Ayaya S, Dicko F, et al. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr. 2013;62(2):208-19.
16. Somi RG. Attrition from HIV care key operational challenge in implementing HIV care and treatment in Tanzania. Ministry of health and social welfare program (NACP); 2012.
17. Ardura-Garcia C, Feldacker C, Tweya H, Chaweza T, Kalulu M, Phiri S, et al. Implementation and operational research: early tracing of children lost to follow-up from antiretroviral treatment: true outcomes and future risks. J Acquir Immune Defic Syndr. 2015;70(5):e160-7.
18. Teshome W, Belayneh M, Moges M, Mekonnen E, Endrias M, Ayele S, et al. Do loss to follow-up and death rates from ART care vary across primary health care facilities and hospitals in south Ethiopia? a retrospective follow-up study. Hiv/Aids. 2015;7:167-74.
19. Halkitis PN, Shrem MT, Zade DD, Wilton L. The physical, emotional and interpersonal impact of HAART: exploring the realities of HIV seropositive individuals on combination therapy. J Health Psychol. 2005;10(3):345-58.
20. Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng'ambi W, Bokosi M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B + PMTCT programme in Lilongwe, Malawi. Trop Med International Health. 2014;19(11):1360-6.
21. Zuniga JA, Yoo-Jeong M, Dai T, Guo Y, Waldrop-Valverde D. The Role of depression in retention in care for persons living with HIV. AIDS Patient Care STDs. 2016;30(1):34-8.
22. WHO. Retention in HIV programmes: defining the challenges and identifying solutions. Geneva: World Health Organization. 2012.
23. Rachlis B, Bakoyannis G, Easterbrook P, Genberg B, Braithwaite RS, Cohen CR, et al. Facility-level factors influencing retention of patients in HIV care in East Africa. PloS ONE. 2016;11(8):e0159994.
24. Kalembo FW, Zgambo M. Loss to followup: a major challenge to successful implementation of prevention of mother-to-child transmission of HIV-1 programs in sub-Saharan Africa. Isrn Aids 2012 . doi: 10.5402/2012/589817.
25. Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012;17(12):1509-20.
26. Gemechu B, Gerbi TH, Tameru B. Psychosocial factors as predictors of HIV/AIDS risky behaviors among people living with HIV/AIDS. J AIDS HIV Res. 2012;1:8-16.
27. Toth M, Messer LC, Quinlivan EB. Barriers to HIV care for women of color living in the Southeastern US are associated with physical symptoms, social environment, and self-determination. AIDS Patient Care STDs. 2013;27(11):613-20.
28. Ribeiro C, Sarmento ECR, Dinis-Ribeiro M, Fernandes L. Effectiveness of psycho-educational intervention in HIV patients' treatment. Front Psychiatr. 2014;5:198.
29. Nakimuli-Mpungu E, Mojtabai R, Alexandre PK, Musisi S, Katabira E, Nachega JB, et al. Lifetime depressive disorders and adherence to anti-retroviral therapy in HIV-infected Ugandan adults: a case-control study. J Affect Disord. 2013;145(2):221-6.
30. Tedaldi EM, van den Berg-Wolf M, Richardson J, Patel P, Durham M, Hammer J, et al. Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States. AIDS Patient Care STDs. 2012;26(12):718-29.
31. Cooperrider DLW. Appreciative Inquiry: a positive revolution in change. In: Holman P, Devane T, editors. The change handbook. Oakland: Berrett-Koehler Publishers, Inc.
32. McCarthy B. Appreciative Inquiry: an alternative to behaviour management. Dementia. 2017;16(2):249-53.
33. Elspeth McAdam AW, Charles Steinberg, Kicki Oljemark, Keith McAdam. Namweza programme overview 2011. http://www.namweza.org/?page_id=145. Accessed 12 Feb 2017.
34. Program Nac. Implementation of HIV/AIDS care and treatment services in Tanzania report. 2013.
35. ® 9.3 Software 2011 (cited 16 Jun 2016). http://support.sas.com/software/93/. Accessed 19 Jan 2017.
36. Somi G. Attrition from HIV care key operational challenge. 2012. http://slideplayer.com/slide/7083119/. Accessed 10 Mar 2017.
37. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939-41.
38. Menon S. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention? J Public Health Policy. 2010;31(4):385-400.
39. Karfakis EKaJ. Current practices to increase uptake, retention and adherence for option B+ in Malawi. Mothers to mothers Malawi 2014 (cited 2016 August 26). https://www.m2m.org/wp-content/uploads/2014/10/m2m_Malawi-PMTCT-Report.pdf
40. Shroufi A, Mafara E, Saint-Sauveur JF, Taziwa F, Vinoles MC. Mother to mother (M2M) peer support for women in prevention of mother to child transmission (PMTCT) programmes: a qualitative study. PloS ONE. 2013;8(6):e64717.